Tristel (TSTL)

Sector:

Health Care

Index:

FTSE AIM 100

380.00p
   
  • Change Today:
    -8.00p
  • 52 Week High: 500.00
  • 52 Week Low: 367.50
  • Currency: UK Pounds
  • Shares Issued: 47.65m
  • Volume: 76,814
  • Market Cap: £181.07m
  • RiskGrade: 180
  • Beta: 0.01

Tristel Overview

We are an infection prevention company. The entire purpose of our business is to prevent the transmission of microbes from one object or person to another. We achieve our mission by applying a very powerful biocidal chemistry – chlorine dioxide – to the target environmental surface or medical device. We are one of a very few companies worldwide that can legitimately claim to be exclusively an infection prevention business.
Competitors: Trellus Health, Open Orphan , Mediclinic International , Cambridge Cognition Holdings, Sourcebio International, Sensyne Health, CareTech Holding, Diaceutics

Key Personnel

CEO: Matthew (Matt) Giovanni Sassone
Executive Director: Bart Leemans
Finance Director: Elizabeth Dixon
Independent Non-Executive Director: Caroline Stephens
Non-Executive Chairman: Bruno Holthof
Senior Independent Director: Isabel J S Napper
Non-Executive Dir: David Orr , Tom Jenkins

Contact Details

Address: Unit 1B Lynx Business Park, Fordham Road, Snailwell, Newmarket, Cambridgeshire , United Kingdom, CB8 7NY
Phone: 44 (0) 1638 721500
Fax: 44 (0) 1638 721911
Website: http://www.tristel.com

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share, FTSE AIM 100
ISIN: GB00B07RVT99

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Tristel Market Data

Currency UK Pounds
Share Price 380.00p
Change Today -8.00p
% Change -2.06 %
52 Week High 500.00
52 Week Low 367.50
Volume 76,814
Shares Issued 47.65m
Market Cap £181.07m
Beta 0.01
RiskGrade 180

Tristel Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.79% below the market average95.79% below the market average95.79% below the market average95.79% below the market average95.79% below the market average
82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average
Price Trend
25.13% below the market average25.13% below the market average25.13% below the market average25.13% below the market average25.13% below the market average
2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average
Income
54.53% below the market average54.53% below the market average54.53% below the market average54.53% below the market average54.53% below the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
32.43% above the market average32.43% above the market average32.43% above the market average32.43% above the market average32.43% above the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Tristel Dividends

  Latest Previous
  Interim Final
Ex-Div 21-Mar-24 23-Nov-23
Paid 12-Apr-24 22-Dec-23
Amount 5.24p 7.88p

Trades for 08-Oct-2024

Time Volume / Share Price
16:26 525 @ 380.00p
16:05 93 @ 380.35p
14:55 12,768 @ 380.00p
14:54 7,500 @ 380.00p
15:53 2,000 @ 380.00p

Tristel Key Personnel

Finance Director Elizabeth Dixon
CEO Matthew (Matt) Giovanni Sassone

Top of Page